197 related articles for article (PubMed ID: 3510760)
21. Dipyridamole for preventing stroke and other vascular events in patients with vascular disease.
De Schryver EL; Algra A; van Gijn J
Cochrane Database Syst Rev; 2003; (1):CD001820. PubMed ID: 12535415
[TBL] [Abstract][Full Text] [Related]
22. Effect of prostaglandin-mediated platelet-suppressant drugs on acute cardiovascular catastrophes.
Sherry S
Adv Prostaglandin Thromboxane Leukot Res; 1982; 10():173-210. PubMed ID: 6216782
[No Abstract] [Full Text] [Related]
23. Effect of dipyridamole and aspirin on late vein-graft patency after coronary bypass operations.
Chesebro JH; Fuster V; Elveback LR; Clements IP; Smith HC; Holmes DR; Bardsley WT; Pluth JR; Wallace RB; Puga FJ
N Engl J Med; 1984 Jan; 310(4):209-14. PubMed ID: 6361561
[TBL] [Abstract][Full Text] [Related]
24. Saphenous vein graft patency 1 year after coronary artery bypass surgery and effects of antiplatelet therapy. Results of a Veterans Administration Cooperative Study.
Goldman S; Copeland J; Moritz T; Henderson W; Zadina K; Ovitt T; Doherty J; Read R; Chesler E; Sako Y
Circulation; 1989 Nov; 80(5):1190-7. PubMed ID: 2680158
[TBL] [Abstract][Full Text] [Related]
25. A platelet-inhibitor-drug trial in coronary-artery bypass operations: benefit of perioperative dipyridamole and aspirin therapy on early postoperative vein-graft patency.
Chesebro JH; Clements IP; Fuster V; Elveback LR; Smith HC; Bardsley WT; Frye RL; Holmes DR; Vlietstra RE; Pluth JR; Wallace RB; Puga FJ; Orszulak TA; Piehler JM; Schaff HV; Danielson GK
N Engl J Med; 1982 Jul; 307(2):73-8. PubMed ID: 7045659
[TBL] [Abstract][Full Text] [Related]
26. [Platelet antiaggregants in the treatment of arterial thrombosis].
Ferlito S
Minerva Cardioangiol; 1991 Oct; 39(10):375-89. PubMed ID: 1803283
[TBL] [Abstract][Full Text] [Related]
27. [Anticoagulant or antiplatelet aggregation treatment after aortocoronary bypass].
Sagnol P; Delahaye JP
Presse Med; 1991 Feb; 20(7):287-90. PubMed ID: 1826353
[No Abstract] [Full Text] [Related]
28. [Antiplatelet drugs (author's transl)].
Dechavanne M; Follea G; Trzeciak MC
Anesth Analg (Paris); 1979; 36(7-8):283-7. PubMed ID: 525834
[TBL] [Abstract][Full Text] [Related]
29. Secondary prevention of myocardial infarction--the present state of the ART.
Mitchell JR
Br Med J; 1980 May; 280(6223):1128-30. PubMed ID: 7000236
[No Abstract] [Full Text] [Related]
30. Optimal antithrombotic therapy following aortocoronary bypass: a meta-analysis.
Fremes SE; Levinton C; Naylor CD; Chen E; Christakis GT; Goldman BS
Eur J Cardiothorac Surg; 1993; 7(4):169-80. PubMed ID: 8481254
[TBL] [Abstract][Full Text] [Related]
31. Effect of drugs of platelets and complications of vascular disease.
Mustard JF; Packham MA; Kinlough-Rathbone RL
Adv Exp Med Biol; 1977; 82():94-105. PubMed ID: 920448
[No Abstract] [Full Text] [Related]
32. [Current clinical results of antiplatelet medication].
Ordinas A
Sangre (Barc); 1984; 29(4-C):833-40. PubMed ID: 6393391
[No Abstract] [Full Text] [Related]
33. [Role of antiplatelet agents in the prevention of cerebral ischemic accidents].
Bousser MG
J Mal Vasc; 1983; 8(1):17-22. PubMed ID: 6341494
[TBL] [Abstract][Full Text] [Related]
34. [Controversy on platelet-inhibiting drugs].
Oelz O
Schweiz Med Wochenschr; 1985 May; 115(20):703-7. PubMed ID: 3892659
[TBL] [Abstract][Full Text] [Related]
35. The thrombogenicity of Dacron arterial grafts and its modification by platelet inhibitory drugs.
Kester RC
Ann R Coll Surg Engl; 1984 Jul; 66(4):241-6. PubMed ID: 6234841
[TBL] [Abstract][Full Text] [Related]
36. Systematic review of randomized controlled trials of aspirin and oral anticoagulants in the prevention of graft occlusion and ischemic events after infrainguinal bypass surgery.
Tangelder MJ; Lawson JA; Algra A; Eikelboom BC
J Vasc Surg; 1999 Oct; 30(4):701-9. PubMed ID: 10514209
[TBL] [Abstract][Full Text] [Related]
37. Primary and secondary prevention of arterial thromboembolism.
Verstraete M
Br Med Bull; 1994 Oct; 50(4):946-65. PubMed ID: 7804741
[TBL] [Abstract][Full Text] [Related]
38. The effect of antiplatelet therapy on saphenous vein coronary artery bypass graft patency.
Sharma GV; Khuri SF; Josa M; Folland ED; Parisi AF
Circulation; 1983 Sep; 68(3 Pt 2):II218-21. PubMed ID: 6347428
[TBL] [Abstract][Full Text] [Related]
39. A perspective on platelet-suppressant drug treatment in coronary artery and cerebrovascular disease.
Genton E
Circulation; 1980 Dec; 62(6 Pt 2):V111-21. PubMed ID: 6108166
[No Abstract] [Full Text] [Related]
40. [Action mechanism and clinical indications for thrombocyte aggregation inhibitors].
Oelz O
Schweiz Med Wochenschr; 1979 Mar; 109(10):348-53. PubMed ID: 424707
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
